MTOR and Alzheimer disease: FTO has been shown to promote the occurrence of insulin defect-related AD by decreasing the TSC1 (TSC Complex Subunit 1) mRNA level, activating the mTOR signaling pathway, and promoting the phosphorylation of tau protein.